NATCO Pharma LimitedNSE: NATCOPHARM

Press Release Aug 09 2023

· Issued by NATCO Pharma Limited

Filed with NSE ·

Natco Pharma Limited has informed the Exchange regarding a press release dated August 09, 2023, titled "NATCO records ₹1160.2 Crore consolidated revenue and ₹420.3 Crore of profit, after tax, for the First Quarter, FY2023-24".

View Attachment

6ix hasn’t read this filing yet.

NATCO Pharma Limited on 6ix

In the deck

Earlier from NATCO Pharma

Later from NATCO Pharma

All NATCO Pharma news releases